Allarity Therapeutics, Inc.
ALLR
$1.28
$0.032.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 345.00K | 345.00K | 320.00K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 345.00K | 345.00K | 320.00K | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 345.00K | 345.00K | 320.00K | -- | -- |
| SG&A Expenses | 5.62M | 6.11M | 6.32M | 10.23M | 10.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -833.00K | -833.00K | -833.00K | -798.00K | -798.00K |
| Total Operating Expenses | 11.14M | 12.60M | 12.93M | 17.00M | 17.10M |
| Operating Income | -10.80M | -12.26M | -12.61M | -17.00M | -17.10M |
| Income Before Tax | -12.33M | -11.25M | -11.23M | -15.31M | -24.47M |
| Income Tax Expenses | -- | -- | -- | 0.00 | -377.00K |
| Earnings from Continuing Operations | -12.33 | -11.25 | -11.23 | -15.31 | -24.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.33M | -11.25M | -11.23M | -15.31M | -24.10M |
| EBIT | -10.80M | -12.26M | -12.61M | -17.00M | -17.10M |
| EBITDA | -8.05M | -9.54M | -12.56M | -16.97M | -17.07M |
| EPS Basic | -0.79 | -0.72 | -0.80 | -2.31 | -9.83 |
| Normalized Basic EPS | -0.49 | -0.45 | -0.50 | -1.44 | -2.22 |
| EPS Diluted | -0.79 | -0.72 | -0.80 | -2.31 | -9.83 |
| Normalized Diluted EPS | -0.49 | -0.45 | -0.50 | -1.44 | -2.22 |
| Average Basic Shares Outstanding | 62.58M | 62.22M | 57.40M | 45.76M | 32.60M |
| Average Diluted Shares Outstanding | 62.58M | 62.22M | 57.40M | 45.76M | 32.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |